Is P-Glycoprotein a Sufficient Marker for Multidrug Resistance in Vivo? Immunohistochemical Staining for P-Glycoprotein in Children and Adult Leukemia: Correlation with Clinical Outcome

References

• Riordan J. R., Ling V. Genetic and biochemical characterization of multidrug resistance. Pharmac. Ther. 1985; 28: 51–75
   PubMed Web of Science ®Google Scholar
• Deuchars K. L., Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin. Oncol. 1989; 16: 156–165
   PubMed Web of Science ®Google Scholar
• Roninson I. B. The role of the MDRI (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol. 1992; 43: 95–102
   PubMed Web of Science ®Google Scholar
• Chen Ch., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., Roninson I. B. Internal duplication and homology with bacterial transport proteins in the mdrl (P-Glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–389
   PubMed Web of Science ®Google Scholar
• Goldstein L. I., Galski H., Fojo A., Willingham M., Lai S. L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G. M., Lieber M., Cossman J., Gottesman M. M., Pastan I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Van Der Bliek A. M., Baas A., Van Der Velde-Koerts T., Biedler J. L., Meyers M. B., Ozols R. F., Hamilton T. C., Joenje H., Borst P. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 1988; 48: 5927–5932
   PubMed Web of Science ®Google Scholar
• Shen D. W., Fojo A., Roninson I. B., Chin J. E., Soffir R., Pastan I., Gottesman M. M. Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdrl gene. Mol. Cell Biol. 1986; 6: 4039–4044
   PubMed Web of Science ®Google Scholar
• Sonneveld P., Nooter K., Burghouts J. T., Herweijer H., Adriaansen H. J., Van Dongen J. J. High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood 1992; 79: 1496–1500
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Boccia J., Casals D., Bertino J. R., Melamed M. R. Expression of the multidrug resiatance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem, Cytochem. 1990; 38: 1277–1287
   PubMed Web of Science ®Google Scholar
• Pileri S. A., Sabattini E., Falini B., Tazzari P. L., Gherlinzoni F., Michieli M. G., Damiani D., Zucchini L., Gobbis M., Tsuruo T., Baccarani M. Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathol. 1991; 19: 131–140
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 7735–7738
   PubMed Web of Science ®Google Scholar
• Van Kalken C. K., Giaccone G., Van Der Valk P., Kuiper C. M., Hadisaputro M. M. N., Bosma S. A. A., Scheper R. J., Meijer C. J. L. M., Pinedo H. M. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am. J. Pathol. 1992; 141: 1063–1072
   PubMed Web of Science ®Google Scholar
• Shen D. W., Fojo A., Chin J. E., Roninson I. B., Richert N., Pastan I., Gottesman I. Human multidrug-resistant cell lines: Increased mdr 1 expression can precede gene amplification. Science 1987; 232: 643–6445
   Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of multidrug-resistance in human tumors and tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedle J. L., Melamed M. R., Bertino J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barier sites. Proc. Natl. Acad. Sci. USA 1989; 86: 695–698s
   PubMed Web of Science ®Google Scholar
• Kartner N., Evernden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820–823
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Laurent G., Chittal S., Tsuruo T., Soues S., Muller C., Charcosset J. Y., Alard C., Brousset P., Mazerrolles C., Delsol G. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br. J. Cancer 1990; 62: 177–182
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 1989; 37: 159–164
   PubMed Web of Science ®Google Scholar
• Kaczorowski S., Porwit A., Christensson B. Expression of P-glycoprotein in Non-Hodgkin's lymphomas. Leuk, Lymph. 1991; 5: 379–386
   PubMed Web of Science ®Google Scholar
• Ucci G., Petrini M., Riccardi A., Invernizzi R., Carulli G., Luoni R., Giordano M., Danova M. Expression of p170 protein in multiple myeloma: a clinical study. Hematol. Oncol. 1992; 10: 213–220
   PubMed Web of Science ®Google Scholar
• Gruber A., Vitols S., Norgren S., Arestroem I., Peterson C., Bjoerkholm M., Reizenstein P., Luthman H. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. Br. J. Cancer 1992; 66: 266–272
   PubMed Web of Science ®Google Scholar
• Pirker R., Wallner J., Geissler K., Linkesch W., Haas O. A., Bettelheim P., Hopfner M., Scherrer R., Havelec L., Ludwig H., Lechner K. MDRI gene expression and treatment outcome in acute meloid leukemia. J. Natl. Cancer Inst. 1991; 83: 708–712
   PubMed Web of Science ®Google Scholar
• Sato H., Preisler H., Day Raza A., Larson R., Browman G., Goldberg J., Vogler R., Grunwald H., Gottlieb A., Bennet J., Gottesman M., Pastan I. MDRI transcript levels as an indication of resistant disease in acute myelogenous leukemia. Br. J. Haematol. 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Musto P., Melillo L., Lombardi G., Matera R., Di Giorgio D., Carotenuto M. High risk of early resistant relapse for leukaemic patients with presence of multidrug associated P-glycoprotein positive cells in complete remission. Br. J. Haematol. 1991; 77: 50–53
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias (FAB) cooperative group. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Scheper J. R., Bulte J. W. M., Brakkee J. G. P., Quak J. J., Van Der Schoot E., Balm A. J. M., Meijer C. J. L. M., Broxterman H. J., Kuiper C. M., Lankelma J., Pinedo H. M. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int. J. Cancer 1988; 42: 389–394
   PubMed Web of Science ®Google Scholar
• Hamada H., Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1986; 83: 7785–7789
   PubMed Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Van Der Valk P., Van Kalken C. K., Katelaars H., Broxterman H. J., Scheffer G., Kuiper C. M., Tsuruo T., Lankelma J., Meijer C. J. L. M., Pinedo H. M., Scheper R. J. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Annals of Oncol. 1990; 1: 56–64
   PubMed Web of Science ®Google Scholar
• Weinstein R. S., Kuszak J. R., Jakate S. M., Lebovitz M. D., Kluskens L. F., Coon J. S. ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter. Hum. Pathol. 1990; 21: 949–958
   PubMed Web of Science ®Google Scholar
• Nooter K., Sonneveld P., Janssen A., Oostrum R., Boersma T., Herweijer H., Valerio D., Hagemeijer A., Baas F. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Int. J. Cancer 1990; 45: 626–631
   PubMed Web of Science ®Google Scholar
• Herweijer H., Sonneveld P., Baas F., Nooter K. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl. Cancer Inst. 1990; 82: 1133–1140
   PubMed Web of Science ®Google Scholar
• Herweijer H., Nooter K., Beishuizen A., Sonneweld P., Oosrum R. G., Hesseling-Janssen A. L. W., Van Dongen J. J. M. Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukemia. Eur. J. Cancer 1991; 27: 297–298
   PubMed Web of Science ®Google Scholar
• Georges E., Bradley G., Geriepy J., Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1990; 87: 152–156
   PubMed Web of Science ®Google Scholar
• Garberoglio C., Dudas M., Casper E. S., Bertino J., Cordon-Cardo C. Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Arch. Patol. Lab. Med. 1992; 116: 1055–1061
   PubMed Web of Science ®Google Scholar
• Finstad C. L., Yin B. W. T., Gordon C. M., Federici M. G., Welt S., Lloyd K. O. Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contains antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis. J. Histochem. Cytochem. 1991; 39: 1603–1610
   PubMed Web of Science ®Google Scholar
• Sugawara I., Kataoka I., Morishita Y., Hamada H., Tsuruo T., Itoyama S., Mori S. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by monoclonal antibody MRK16. Cancer Res. 1988; 48: 1926–1929
   PubMed Web of Science ®Google Scholar
• Georges E., Tsuruo T., Ling V. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. J. Biol. Chem. 1993; 268: 1792–1798
   PubMed Web of Science ®Google Scholar
• Ito Y., Tanimoto M., Kumazawa T., Okumura M., Morishima Y., Ohno R., Saito H. Increased P-glycoprotein expression and multidrug resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Cancer 1989; 63: 1534–1538
   PubMed Web of Science ®Google Scholar
• Holmes J., Jacobs A., Carter G., Janowska-Wieczorek A., Padua R. A. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Br. J. Haematol. 1989; 72: 40–44
   PubMed Web of Science ®Google Scholar
• Musto P., Cascavilla N., Di Renzo N., Ladogana S., La Sala A., Melillo L., Nobile M., Matera R., Lombardi G., Carotenuto M. Clinical relevance of immunocytochemical detection of multidrug resistance associated P-glycoprotein in hematologic malignancies. Tumori 1990; 76: 353–359
   PubMed Web of Science ®Google Scholar
• Ma D. D. F., Davey R. A., Harman D. H., Isbister J. P., Scurr R. D., Makertich S. M., Dowden G., Bell D. R. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet 1987; 135–137
   PubMed Web of Science ®Google Scholar
• Goasguen J. E., Dossot J. M., Fardel O., Lemee F., Le Gall E., Leblay R., Leprise P. Y., Chaperon J., Fauchet R. Expression of the multidrug resistance associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implication. Blood 1993; 81: 2394–2398
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y., Yoshimura A., Hanada S., Utsunomiya A., Makino T., Ishibashi K., Kodama M., Iwashashi M., Arima T., Akiyama S. I. Expression of the multidrug transporter P-glycoprotein in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868–873
   PubMed Web of Science ®Google Scholar
• Michieli M., Damiani D., Geromin A., Michelutti A., Fanin R., Raspadori D., Russo D., Visani G., Dinota A., Pileri S. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia. Eur. J. Haematol. 1992; 48: 87–92
   PubMed Web of Science ®Google Scholar
• Zhou D. C., Marie J. P., Suberville A. M., Zittoun R. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6: 879–885
   PubMed Web of Science ®Google Scholar
• Mizuno Y., Hara T., Nagata M., Tawa A., Tsuruo T., Ueda K. Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma. Eur. J. Pediatr. 1991; 150: 416–418
   PubMed Web of Science ®Google Scholar
• Michieli M., Raspadori D., Damiani D., Geromin A., Gallizia C., Michelutti A., Fanin R., Fasola G., Russo D., Tazzari P., Pileri S., Mallardi F., Baccarani M. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukemia. Br. J. Haematol. 1991; 77: 460–465
   PubMed Web of Science ®Google Scholar
• Kellen J. A. Molecular interrelationships in multidrug resistance (Review). Anticancer Res. 1994; 14: 433–436
   PubMed Web of Science ®Google Scholar
• Drach D., Zhao S., Drach J., Mahadevia R., Gattringer C., Huber H., Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistance phenotype. Blood 1992; 80: 2729–2734
   PubMed Web of Science ®Google Scholar
• Kemnitz J., Freund M., Dominis M., Cohnert T. R., Uysal A., Georgii A. Detection of cells with multidrug-resistant phenotype in myeloproliferative disorders before therapy. Hematologic Pathol. 1989; 3: 73–78
   PubMedGoogle Scholar
• Neyfakh A. A., Serpinskaya A. S., Chervonsky A. V., Apasov S. G., Kazarov A. R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 1989; 185: 496–505
   PubMed Web of Science ®Google Scholar